Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | DPP7 | Q9UHL4 | 3/20 | 0.37 |
| ▸ | DPP4 | P27487 | 2/20 | 0.37 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.37 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.37 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.36 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.36 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.34 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.33 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.33 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.33 |
| ▸ | TLR2 | O60603 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19547630 | 0.94 | GSR (0.52) | GSRTSHRDPP7DPP4DPP8 | |
| Trifluoroacetic Acid SCHEMBL7444619 | 0.89 | GSR (0.40) | GSRTSHRDPP7DPP4DPP8 | |
| SCHEMBL19547621 | 0.83 | GSR (0.42) | GSRDPP7DPP4DPP8DPP9 | |
| SCHEMBL18945034 | 0.82 | TSHR (0.39) | GSRTSHRALDH1A1CYP1A2CPB2 | |
| SCHEMBL29194171 | 0.81 | GSR (0.50) | GSRDPP7DPP4DPP8DPP9 | |
| SCHEMBL26660574 | 0.81 | GRIK1 (0.45) | DPP7GNAI3GNAO1GNAI1SLC15A1 | |
| SCHEMBL14486200 | 0.81 | GSR (0.59) | GSRTSHRCYP1A2CPB2 | |
| SCHEMBL5532424 | 0.80 | NOS2 (0.39) | TSHRALDH1A1SLC15A1SLC7A5 | |
| SCHEMBL5532428 | 0.80 | NOS2 (0.39) | TSHRALDH1A1SLC15A1SLC7A5 | |
| SCHEMBL61007 | 0.80 | TSHR (0.41) | TSHRALDH1A1SLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10292940-B2 | Hyaluronic acid-based amphiphilic polymer, preparation method and application thereof | BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD. (CN) | 2019-05-21 | — | — | US | disclosed |
| US-20180092858-A1 | Hyaluronic Acid-Based Amphiphilic Polymer, Preparation Method and Application Thereof | BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD. (CN) | 2018-04-05 | — | — | US | disclosed |
| EP-3241852-A1 | HYALURONIC ACID-BASED AMPHIPHILIC POLYMER, PREPARATION METHOD AND APPLICATION THEREOF | BrightGene Bio-Medical Technology Co., Ltd. (CN) | 2017-11-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10292940-B2 | Hyaluronic acid-based amphiphilic polymer, preparation method and application thereof | CD44, HCAR1, ASGR1 | GSR 3774/4885TSHR 745/4885DPP7 1318/4885 |
| US-20180092858-A1 | Hyaluronic Acid-Based Amphiphilic Polymer, Preparation Method and Application Thereof | CD44, HCAR1, ASGR1 | GSR 3774/4885TSHR 745/4885DPP7 1318/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.